NASDAQ:MRTX
Delisted

Mirati Therapeutics Stock News

etoro logo Buy MRTX
*Your capital is at risk
$58.70
+0 (+0%)
At Close: Apr 19, 2024
In a report released today, Jay Olson from Oppenheimer maintained a Buy rating on Mirati Therapeutics (MRTX – Research Report),
Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to developing and commercializing new medicines
In a report released today, Evan Seigerman from Credit Suisse maintained a Buy rating on Mirati Therapeutics (MRTX – Research
JonesTrading analyst Soumit Roy reiterated a Buy rating on Mirati Therapeutics (MRTX – Research Report) today. The company’s shares closed
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results and a corporate update for the second quarter ended June 30, 2020.
Charles Baum became the CEO of Mirati Therapeutics, Inc. (NASDAQ:MRTX) in 2012, and we think it's a good time to look...
The best 5G stocks to invest in will change over time. The consumer smartphone market will evolve into broader 5G wireless enterprise opportunities.
GREENSBORO, N.C., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, today announced that Company executives are scheduled
How can the market stay so overbought? The answer is simple: there is no selling. When there's little supply, stocks don't sink.
Relations between the United States and China have worsened over the last few years. The trade tariffs, the novel coronavirus, the Hong Kong security law, the closure of consulates, and China’s exp
Here's why Qualcomm surged on Thursday. Trade the stock along with two other chip names using these tactical ideas.
The mobile phone and Wi-Fi chip company posted June quarter results and September quarter guidance that were well above Street expectations.
Qorvo (NASDAQ:QRVO) has had a great run on the share market with its stock up by a significant 24% over the last three...

Qorvo Jumps On Sales Outlook

02:32pm, Thursday, 30'th Jul 2020
Chipmaker Qorvo gapped up to a 19-year high on strong earnings and a bullish outlook.
Qorvo (QRVO) shares are up 7.4% in Thursday's pre-market trading thanks to better-than-expected 1Q earnings and upbeat guidance. Its adjusted earnings rose 10.3% to $1.50 per share and beat analysts�
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE